For instance, Burley et al. (2018), showed that reduction in cellular proliferation and GBM tumor growth could be achieved using EGFR VIII-targeted NIR-PIT [9, 12, 39, 41, 91, 153–155]. This evidence concerns the gene EGFR and glioblastoma.